Science Current Events | Science News | Brightsurf.com
 

HIV Rate Current Events | HIV Rate News | 5
Page 5 of 39 | 956 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
Scientists glimpse a rare human antibody which protects against AIDS
Scientists have obtained their first detailed glimpse of a rare antibody, called b12, which is capable of inactivating many different strains of HIV, the virus which causes AIDS. A crystal structure of b12 has been determined by scientists working at The Scripps Research Institute, California, and... view more (2001-08-08)

The release of new data from the HVTN 502 HIV vaccine study
The new analyses revealed today from the STEP HIV vaccine clinical trial are both disappointing and puzzling. At this time, the data offer no clear explanations as to why the vaccine showed no measurable efficacy or why among individuals with background immunity to the adenovirus vector, there were... view more (2007-11-08)

New Therapeutic Vaccine for HIV/AIDS Eliminates Needles and Excessive Toxicity
DermaVir, a novel treatment for HIV/AIDS, offers a new option which complements and improves present drug therapies. The vaccine, applied topically to the skin, has demonstrated efficacy in boosting immune responses and controlling virus replication in chronically infected monkeys. This treatment... view more (2005-01-06)

Preventing mother-to-child HIV transmission in low-income countries
Can HIV transmission in pregnancy in low income settings be prevented with round the clock rapid testing in labor?   view more (2008-05-06)

Hopkins study suggests commercially available antibiotic may help fight dementia in HIV patients
An antibiotic commonly used to treat a variety of serious infections may also help prevent dementia in HIV patients, according to a test-tube study of human brain cells by Johns Hopkins University School of Medicine neurologist Jeffrey Rumbaugh, M.D., Ph.D.   view more (2006-04-06)

UT Southwestern researchers refocus studies on patients with HIV, hepatitis
As HIV patients live longer thanks to advanced therapies, researchers are looking for better ways to treat accompanying maladies such as hepatitis that traditionally were not emphasized.   view more (2006-10-12)

Anti-HIV drugs unlikely to stop HIV spread
Researchers believe antiretroviral therapy (ART) will not be effective in stopping HIV epidemics even if it is made universally available in poorer countries, and that widespread use could even lead to an increase in the numbers infected with HIV.   view more (2006-03-14)

Study finds fears of HIV transmission in families with infected parent
Despite ongoing efforts to educate the public about HIV, a new study by researchers from UCLA, the RAND Corp., Harvard University and Children's Hospital Boston has found that two-thirds of families with an HIV-infected parent experience fears about spreading HIV in the home.   view more (2008-11-04)

Hope For South Africa - At Last (p 501)
This week's editorial urges the South African Government to implement new recommendations to provide antiretroviral treatment to tackle the country's grave HIV/AIDS epidemic. Three recent developments are detailed that offer some hope to the nearly 5 million South Africans living with HIV/AIDS: the... view more (2003-08-13)

HIV positive employees face job loss and workplace discrimination
HIV positive employees face unemployment and workplace discrimination, indicates a study published ahead of print in Occupational and Environmental Medicine.   view more (2007-10-03)

Abacavir Could Play Important Future Role In Treatment Of Children With HIV-1 (p 733)
Results of the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial, published in this week's issue of THE LANCET, suggest an important future role for the drug abacavir in the treatment of children with HIV-1. Antiretroviral HIV-1 drug treatment for adults in more-developed countries... view more (2002-02-28)

Male circumcision for HIV prevention and more
Three clinical trials in Africa found that adult male circumcision reduced the risk of men acquiring HIV infection from heterosexual sex by 51-60%.   view more (2007-07-24)

Biology not behaviour could explain reduced risk of HIV infection for circumcised men (p 1039)
Research from India published in this week's issue of THE LANCET suggests that circumcised men could be over six times less likely than uncircumcised men to acquire HIV infection. The study also shows how the explanation for this decreased risk in circumcised men is likely to be biological rather... view more (2004-03-24)

HIV-1-Positive Women At Increased Risk Of Genital Cancer
A study in this week's issue of THE LANCET suggests that women who are HIV-1 positive are at an increased risk of invasive genital cancer. Authors of the study recommend that gynaecological examination of these women should include examination of the vulva and perianal region to identify genital... view more (2002-01-11)

New insights into vaccination for HIV
A group of Australian researchers at the Universities of Melbourne and New South Wales have developed new tools and paradigms to understand immune evasion from HIV.   view more (2008-01-25)

Common parasitic infection leads to increased risk for HIV infection
A new study shows a significantly increased risk of HIV infection among women with a common sexually transmitted disease, trichomoniasis. Although studies have been undertaken in the past to show the link between sexually transmitted infections and susceptibility to HIV.   view more (2007-01-29)

Study finds strong demand for HIV meds after high-risk sex
People who do not have HIV but seek antiretroviral medications following high-risk sexual encounters are very likely to complete the full monthlong drug regimen, according to a new UCLA AIDS Institute study. Moreover, there is a strong demand for publicly available post-exposure prophylaxis among... view more (2007-11-09)

Increased HIV risk for women with violent male partners (pp 1410, 1415)
South African research published in this week's issue of THE LANCET highlights how women with physically violent and controlling male partners are at an increased risk of HIV-1 infection. HIV/AIDS is more widespread among women in sub-Saharan Africa than any other population. Although violence... view more (2004-04-28)

Body's anti-HIV drug explained
Humans have a built-in weapon against HIV, but until recently no one knew how to unlock its potential.   view more (2008-10-13)

Science commentary stresses need for collaboration at local level in HIV-prevention studies
Clinical trials of drugs intended to prevent HIV infection in high-risk populations must be developed and carried out in close collaboration with the local communities and national governments of the countries in which they are conducted, according to 18 international leaders in HIV prevention... view more (2005-10-03)

Human testis harbors HIV-1 in resident immune cells
Researchers have demonstrated HIV replication within resident immune cells of the testis, providing an explanation for the persistence of virus in semen even after effective highly active antiretroviral therapy.   view more (2006-11-27)

Protein that provides innate defense against HIV could lead to new treatments
By identifying a protein that restricts the release of HIV-1 virus from human cells, scientists believe they may be closer to identifying new approaches to treatment. The research is published in the advance online edition of Nature Medicine.   view more (2008-05-27)

Implications of the new HIV estimate for India
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.   view more (2007-12-04)

HIV shifting from most to least educated in sub-Saharan Africa
HIV infections appear to be concentrating among the least educated people in Africa, reversing previous patterns which saw higher levels of infection among the most educated, according to a study published today in the journal AIDS.   view more (2008-01-16)

"EuroVacc 02" HIV Vaccine trial begins
The European Vaccine Effort against HIV/AIDS, today announced that a phase I clinical trial of novel investigational vaccines comprising DNA-HIV-C and NYVAC-HIV-C for the prevention of HIV infection has started in Lausanne and London in February 2005. These vaccines are based on HIV subtype C,... view more (2005-02-16)
Page 5 of 39 | 956 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com